Jaguar Health第二季度每股收益$（4.04）低于$（1.11）估计，销售额272万美元低于394万美元估计

Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(4.04) per share which missed the analyst consensus estimate of $(1.11) by 263.96 percent. This is a 861.9 percent decrease over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $2.72 million which missed the analyst consensus estimate of $3.94 million by 30.93 percent. This is a 1.64 percent increase over sales of $2.68 million the same period last year.